Clinical outcomes
| Variable | All patients | Stable CAD | ACS | p Value Stable CAD vs ACS |
| No of patients | 2877 | 1793 | 1084 | – |
| Patients with clinical follow-up at 9 months or early event, n (%) | 2513 (87.3) | 1566 (87.3) | 947 (87.4) | 0.986 |
| Follow-up time (months) | 8.7±1.8 | 8.6±1.9 | 9.0±1.7 | <0.001 |
| Time to discharge, median (IQR) (days) | 2.0 (2.0) (3.7±13.6) | 1.0 (1.0) (3.3±15.8) | 3 (4.0) (4.4±8.8) | 0.021 |
| Inhospital MACE, n (%) | 41 (1.4) | 11 (0.6) | 30 (2.8) | <0.001 |
| Inhospital TLR, n (%) | 14 (0.5) | 5 (0.3) | 9 (0.8) | 0.039 |
| Inhospital MI, n (%) | 25 (0.9) | 6 (0.3) | 19 (1.8) | <0.001 |
| Inhospital cardiac death, n (%) | 17 (0.7) | 4 (0.2) | 13 (1.2) | 0.001 |
| 9-month MACE, n (%) | 108 (4.3) | 50 (3.2) | 58 (6.1) | <0.001 |
| 9-month TLR (re-PCI, CABG), n (%) | 58 (2.3) | 33 (2.1) | 25 (2.6) | 0.389 |
| 9-month MI, n (%) | 58 (2.3) | 17 (1.1) | 41 (4.3) | <0.001 |
| 9-month all-cause death, n (%) | 38 (1.5) | 14 (0.9) | 24 (2.5) | <0.001 |
| 9-month accumulated definite/probable stent thrombosis, n (%) | 17 (0.7) | 9 (0.6) | 8 (0.8) | 0.424 |
| Acute stent thrombosis, ≤24 hours, n (%) | 9 (0.4) | 4 (0.3) | 5 (0.5) | 0.372 |
| Subacute stent thrombosis, 1–30 days, n (%) | 1 (0.0) | 0 (0.0) | 1 (0.1) | |
| Late stent thrombosis, ≥30 days, n (%) | 7 (0.3) | 5 (0.3) | 2 (0.2) |
ACS, acute coronary syndrome; CABG, coronary artery bypass grafting; CAD, coronary artery disease; MACE; major adverse cardiac events; MI, myocardial infarction; re-PCI, re-percutaneous coronary intervention; TLR, target lesion revascularisation.